Mark D Huffman, Abigail S Baldridge, Danielle Lazar, Hiba Abbas, Jairo Mejia, Fallon M Flowers, Adriana Quintana, Alema Jackson, Namratha R Kandula, Donald M Lloyd-Jones, Stephen D Persell, Sadiya S Khan, James J Paparello, Aashima Chopra, Priya Tripathi, My H Vu, Clara K Chow, Jody D Ciolino
New approaches are needed to lower blood pressure (BP) given persistently low control rates. QUARTET USA sought to evaluate the effect of four-drug, quarter-dose BP lowering combination in patients with hypertension. QUARTET USA was a randomized (1:1), double-blinded trial conducted in federally qualified health centers among adults with hypertension. Participants received either a quadpill of candesartan 2 mg, amlodipine 1.25 mg, indapamide 0.625 mg, and bisoprolol 2.5 mg or candesartan 8 mg for 12 weeks...
April 8, 2024: Hypertension Research: Official Journal of the Japanese Society of Hypertension